Check out our mini-webinar on a topic that has gained significant attention across the long-term care industry: the use of antipsychotic medications and the new CMS guidelines governing their appropriate use.
In this session, we break down CMS’s new “hybrid” measure and what it means for your organization. Learn how this change impacts your Five-Star Rating in two critical ways — annual surveys and quality measures — and what you should be doing now to stay compliant and proactive.
We cover:
- An overview of the new CMS guidelines for antipsychotic use
- How the hybrid measure works and why it matters
- Who is included and excluded for this measure
- Gradual Dose Reduction requirements
- IDT involvement and nonpharmacological interventions
